131 related articles for article (PubMed ID: 38588920)
41. Outcomes of salvage radiation for recurrent world health organization grade II meningiomas: a retrospective cohort study.
Momin AA; Shao J; Soni P; Almeida JP; Suh JH; Murphy ES; Chao ST; Angelov L; Mohammadi AM; Barnett GH; Recinos PF; Kshettry VR
J Neurooncol; 2021 Apr; 152(2):373-382. PubMed ID: 33590402
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of Proton Therapy Reirradiation for Patients With Recurrent Head and Neck Squamous Cell Carcinoma.
Lee A; Woods R; Mahfouz A; Kitpanit S; Cartano O; Mohamed N; Youssef I; Marqueen K; Sine K; Mah D; Neal B; Zakeri K; Kang JJ; Riaz N; Yu Y; McBride SM; Chen LD; Tsai CJ; Gelblum DY; Press RH; Michel LS; Sherman EJ; Pfister D; Dunn LA; Ho AL; Fetten J; Wong RJ; Boyle JO; Singh B; Cracchiolo JR; Ganly I; Cohen MA; Lee NY
JAMA Netw Open; 2023 Jan; 6(1):e2250607. PubMed ID: 36689229
[TBL] [Abstract][Full Text] [Related]
43. Dose escalation with proton radiation therapy for high-grade meningiomas.
Chan AW; Bernstein KD; Adams JA; Parambi RJ; Loeffler JS
Technol Cancer Res Treat; 2012 Dec; 11(6):607-14. PubMed ID: 22712601
[TBL] [Abstract][Full Text] [Related]
44. Dosimetric comparison of protons vs photons in re-irradiation of intracranial meningioma.
Poel R; Stuessi Lobmaier A; Andratschke N; Unkelbach J; Tanadini-Lang S; Guckenberger M; Foerster R
Br J Radiol; 2019 Aug; 92(1100):20190113. PubMed ID: 31264474
[TBL] [Abstract][Full Text] [Related]
45. Long-term outcome of moderate hypofractionated stereotactic radiotherapy for meningiomas.
Maranzano E; Draghini L; Casale M; Arcidiacono F; Anselmo P; Trippa F; Giorgi C
Strahlenther Onkol; 2015 Dec; 191(12):953-60. PubMed ID: 26490452
[TBL] [Abstract][Full Text] [Related]
46. Clinical outcome after particle therapy for meningiomas of the skull base: toxicity and local control in patients treated with active rasterscanning.
El Shafie RA; Czech M; Kessel KA; Habermehl D; Weber D; Rieken S; Bougatf N; Jäkel O; Debus J; Combs SE
Radiat Oncol; 2018 Mar; 13(1):54. PubMed ID: 29587795
[TBL] [Abstract][Full Text] [Related]
47. Management trends for anaplastic meningioma with adjuvant radiotherapy and predictors of long-term survival.
Alhourani A; Aljuboori Z; Yusuf M; Woo SY; Hattab EM; Andaluz N; Williams BJ
Neurosurg Focus; 2019 Jun; 46(6):E4. PubMed ID: 31153143
[TBL] [Abstract][Full Text] [Related]
48. World Health Organization Grade II Meningiomas: The Role of Adjuvant/Salvage Gamma Knife Surgery After Initial Surgery and Prognostic Factor Assessment.
Liu X; Shan B; Wang M; Xu J
World Neurosurg; 2018 Jan; 109():e352-e362. PubMed ID: 28987849
[TBL] [Abstract][Full Text] [Related]
49. Revisiting Adjuvant Radiotherapy After Gross Total Resection of World Health Organization Grade II Meningioma.
Graffeo CS; Leeper HE; Perry A; Uhm JH; Lachance DJ; Brown PD; Ma DJ; Van Gompel JJ; Giannini C; Johnson DR; Raghunathan A
World Neurosurg; 2017 Jul; 103():655-663. PubMed ID: 28450233
[TBL] [Abstract][Full Text] [Related]
50. Long-term outcomes and safety after reirradiation in locally recurrent nasopharyngeal carcinoma in a non-endemic area.
Boustani J; Ruffier A; Moya-Plana A; Tao Y; Nguyen F; Even C; Berthold C; Casiraghi O; Temam S; Blanchard P
Strahlenther Onkol; 2021 Mar; 197(3):188-197. PubMed ID: 32514613
[TBL] [Abstract][Full Text] [Related]
51. Subventricular zone involvement at recurrence is a strong predictive factor of outcome following high grade glioma reirradiation.
Attal J; Chaltiel L; Lubrano V; Sol JC; Lanaspeze C; Vieillevigne L; Latorzeff I; Cohen-Jonathan Moyal E
J Neurooncol; 2018 Jan; 136(2):413-419. PubMed ID: 29273890
[TBL] [Abstract][Full Text] [Related]
52. Factors predicting local tumor control after gamma knife stereotactic radiosurgery for benign intracranial meningiomas.
DiBiase SJ; Kwok Y; Yovino S; Arena C; Naqvi S; Temple R; Regine WF; Amin P; Guo C; Chin LS
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1515-9. PubMed ID: 15590183
[TBL] [Abstract][Full Text] [Related]
53. Adjuvant radiotherapy for atypical meningiomas.
Bagshaw HP; Burt LM; Jensen RL; Suneja G; Palmer CA; Couldwell WT; Shrieve DC
J Neurosurg; 2017 Jun; 126(6):1822-1828. PubMed ID: 27611201
[TBL] [Abstract][Full Text] [Related]
54. Long-term outcomes of fractionated stereotactic radiotherapy for intracranial skull base benign meningiomas in single institution.
Onodera S; Aoyama H; Katoh N; Taguchi H; Yasuda K; Yoshida D; Surtherland K; Suzuki R; Ishikawa M; Gerard B; Terasaka S; Shirato H
Jpn J Clin Oncol; 2011 Apr; 41(4):462-8. PubMed ID: 21177777
[TBL] [Abstract][Full Text] [Related]
55. Re-irradiation for locally recurrent refractory breast cancer.
Merino T; Tran WT; Czarnota GJ
Oncotarget; 2015 Oct; 6(33):35051-62. PubMed ID: 26459388
[TBL] [Abstract][Full Text] [Related]
56. Atypical and malignant meningiomas: Considerations for treatment and efficacy of radiotherapy.
Cain SA; Smoll NR; Van Heerden J; Tsui A; Drummond KJ
J Clin Neurosci; 2015 Nov; 22(11):1742-8. PubMed ID: 26213286
[TBL] [Abstract][Full Text] [Related]
57. Reirradiation for Recurrent Pediatric Central Nervous System Malignancies: A Multi-institutional Review.
Rao AD; Rashid AS; Chen Q; Villar RC; Kobyzeva D; Nilsson K; Dieckmann K; Nechesnyuk A; Ermoian R; Alcorn S; MacDonald SM; Ladra MM; Ford EC; Winey BA; Figueiredo MLS; Chen MJ; Terezakis SA
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):634-641. PubMed ID: 29280457
[TBL] [Abstract][Full Text] [Related]
58. Long-term surgical outcome and biological prognostic factors in patients with skull base meningiomas.
Ohba S; Kobayashi M; Horiguchi T; Onozuka S; Yoshida K; Ohira T; Kawase T
J Neurosurg; 2011 May; 114(5):1278-87. PubMed ID: 21166572
[TBL] [Abstract][Full Text] [Related]
59. Long-term outcome after radiotherapy in patients with atypical and malignant meningiomas--clinical results in 85 patients treated in a single institution leading to optimized guidelines for early radiation therapy.
Adeberg S; Hartmann C; Welzel T; Rieken S; Habermehl D; von Deimling A; Debus J; Combs SE
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):859-64. PubMed ID: 22137023
[TBL] [Abstract][Full Text] [Related]
60. Histopathological features predictive of local control of atypical meningioma after surgery and adjuvant radiotherapy.
Chen WC; Magill ST; Wu A; Vasudevan HN; Morin O; Aghi MK; Theodosopoulos PV; Perry A; McDermott MW; Sneed PK; Braunstein SE; Raleigh DR
J Neurosurg; 2018 Apr; 130(2):443-450. PubMed ID: 29624151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]